<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03871530</url>
  </required_header>
  <id_info>
    <org_study_id>1023951</org_study_id>
    <nct_id>NCT03871530</nct_id>
  </id_info>
  <brief_title>A Novel Approach to Optimize Programmed Intermittent Epidural Bolus (PIEB) Delivery for Labour Analgesia</brief_title>
  <official_title>A Novel Approach to Optimize Programmed Intermittent Epidural Bolus (PIEB) Delivery for Labour Analgesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IWK Health Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IWK Health Centre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Programmed intermittent epidural bolus (PIEB) for labour analgesia allows an epidural pump to
      be programmed to deliver small amounts of the local anesthetic and opioid solution at
      regularly timed intervals. However, little evidence is available to guide optimal settings
      for PIEB. The gaps in evidence include: (1) programmed timing for the first PIEB bolus
      (referred to as the &quot;NEXT bolus&quot;) (2) determination of PIEB bolus volume (3) the interval for
      subsequent doses (PIEB interval). Response Surface Methodology will be utilized to best
      estimate the optimal PIEB settings (NEXT bolus interval, PIEB interval time, PIEB volume) by
      using the following clinical primary outcome measures: maternal satisfaction score, need for
      a clinician administered rescue bolus, and the ratio of PCEA boluses requested/delivered.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 29, 2019</start_date>
  <completion_date type="Anticipated">September 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>double-blind randomized trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maternal satisfaction score</measure>
    <time_frame>24 hours following delivery</time_frame>
    <description>quantified as 0-100, where 0 - not satisfied, and 100 - completely satisfied</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of clinician administered rescue boluses</measure>
    <time_frame>Start of labour epidural to delivery time</time_frame>
    <description>Recorded from the Innovian anesthesia database, IntelliSpace Perinatal, or CADD®-Solis Epidural Pump</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ratio of the number of PCEA boluses requested to the number of PCEA boluses delivered</measure>
    <time_frame>Start of labour epidural to delivery time</time_frame>
    <description>Recorded on the CADD®-Solis Epidural Pump during labour and downloaded by research coordinator after delivery</description>
  </primary_outcome>
  <number_of_arms>14</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Labor Pain</condition>
  <arm_group>
    <arm_group_label>Coordinate A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PIEB &quot;Next Bolus&quot;: 45 minutes, PIEB Interval: 50 minutes, and PIEB volume: 5 mL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Coordinate B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PIEB &quot;Next Bolus&quot;: 45 minutes, PIEB Interval: 40 minutes, and PIEB volume: 6.5 mL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Coordinate C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PIEB &quot;Next Bolus&quot;: 45 minutes, PIEB Interval: 50 minutes, and PIEB volume: 8 mL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Coordinate D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PIEB &quot;Next Bolus&quot;: 45 minutes, PIEB Interval: 60 minutes, and PIEB volume: 6.5 mL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Coordinate E</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PIEB &quot;Next Bolus&quot;: 30 minutes, PIEB Interval: 40 minutes, and PIEB volume: 5 mL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Coordinate F</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PIEB &quot;Next Bolus&quot;: 30 minutes, PIEB Interval: 40 minutes, and PIEB volume: 8 mL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Coordinate G</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PIEB &quot;Next Bolus&quot;: 30 minutes, PIEB Interval: 60 minutes, and PIEB volume: 8 mL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Coordinate H</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PIEB &quot;Next Bolus&quot;: 30 minutes, PIEB Interval: 60 minutes, and PIEB volume: 5 mL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Coordinate I</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PIEB &quot;Next Bolus&quot;: 15 minutes, PIEB Interval: 50 minutes, and PIEB volume: 5 mL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Coordinate J</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PIEB &quot;Next Bolus&quot;: 15 minutes, PIEB Interval: 40 minutes, and PIEB volume: 6.5 mL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Coordinate K</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PIEB &quot;Next Bolus&quot;: 15 minutes, PIEB Interval: 50 minutes, and PIEB volume: 8 mL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Coordinate L</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PIEB &quot;Next Bolus&quot;: 15 minutes, PIEB Interval: 60 minutes, and PIEB volume: 6.5 mL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Coordinate M</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PIEB &quot;Next Bolus&quot;: 30 minutes, PIEB Interval: 50 minutes, and PIEB volume: 6.5 mL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Coordinate N</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PIEB &quot;Next Bolus&quot;: 30 minutes, PIEB Interval: 50 minutes, and PIEB volume: 6.5 mL</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Coordinate A</intervention_name>
    <description>PIEB &quot;Next Bolus&quot;: 45 minutes, PIEB Interval: 50 minutes, and PIEB volume: 5 mL</description>
    <arm_group_label>Coordinate A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Coordinate B</intervention_name>
    <description>PIEB &quot;Next Bolus&quot;: 45 minutes, PIEB Interval: 40 minutes, and PIEB volume: 6.5 mL</description>
    <arm_group_label>Coordinate B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Coordinate C</intervention_name>
    <description>PIEB &quot;Next Bolus&quot;: 45 minutes, PIEB Interval: 50 minutes, and PIEB volume: 8 mL</description>
    <arm_group_label>Coordinate C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Coordinate D</intervention_name>
    <description>PIEB &quot;Next Bolus&quot;: 45 minutes, PIEB Interval: 60 minutes, and PIEB volume: 6.5 mL</description>
    <arm_group_label>Coordinate D</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Coordinate E</intervention_name>
    <description>PIEB &quot;Next Bolus&quot;: 30 minutes, PIEB Interval: 40 minutes, and PIEB volume: 5 mL</description>
    <arm_group_label>Coordinate E</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Coordinate F</intervention_name>
    <description>PIEB &quot;Next Bolus&quot;: 30 minutes, PIEB Interval: 40 minutes, and PIEB volume: 8 mL</description>
    <arm_group_label>Coordinate F</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Coordinate G</intervention_name>
    <description>PIEB &quot;Next Bolus&quot;: 30 minutes, PIEB Interval: 60 minutes, and PIEB volume: 8 mL</description>
    <arm_group_label>Coordinate G</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Coordinate H</intervention_name>
    <description>PIEB &quot;Next Bolus&quot;: 30 minutes, PIEB Interval: 60 minutes, and PIEB volume: 5 mL</description>
    <arm_group_label>Coordinate H</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Coordinate I</intervention_name>
    <description>PIEB &quot;Next Bolus&quot;: 15 minutes, PIEB Interval: 50 minutes, and PIEB volume: 5 mL</description>
    <arm_group_label>Coordinate I</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Coordinate J</intervention_name>
    <description>PIEB &quot;Next Bolus&quot;: 15 minutes, PIEB Interval: 40 minutes, and PIEB volume: 6.5 mL</description>
    <arm_group_label>Coordinate J</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Coordinate K</intervention_name>
    <description>PIEB &quot;Next Bolus&quot;: 15 minutes, PIEB Interval: 50 minutes, and PIEB volume: 8 mL</description>
    <arm_group_label>Coordinate K</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Coordinate L</intervention_name>
    <description>PIEB &quot;Next Bolus&quot;: 15 minutes, PIEB Interval: 60 minutes, and PIEB volume: 6.5 mL</description>
    <arm_group_label>Coordinate L</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Coordinate M</intervention_name>
    <description>PIEB &quot;Next Bolus&quot;: 30 minutes, PIEB Interval: 50 minutes, and PIEB volume: 6.5 mL</description>
    <arm_group_label>Coordinate M</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Coordinate N</intervention_name>
    <description>PIEB &quot;Next Bolus&quot;: 30 minutes, PIEB Interval: 50 minutes, and PIEB volume: 6.5 mL</description>
    <arm_group_label>Coordinate N</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Nulliparous,

          -  English speaking

          -  18-45 years

          -  single gestation ≥ 37 weeks

          -  vertex presentation

          -  American Society of Anesthesiologists (ASA) Physical Status II (mild and controlled
             systemic disease and/or pregnancy)

          -  requesting an epidural for labour analgesia

          -  cervical dilation ≤ 7 cm at the time of initiation of epidural analgesia.

        Exclusion Criteria:

          -  Preeclampsia or HELLP syndrome

          -  maternal cardiac disease

          -  severe or uncontrolled maternal systemic disease

          -  contraindication to neuraxial analgesia (i.e. coagulopathy, infection, neuropathy)

          -  abnormal spinal anatomy (i.e. severe scoliosis, spina bifida, spinal instrumentation)

          -  chronic analgesic use

          -  a physical or psychiatric condition which may impair cooperation

          -  known fetal anomalies/intrauterine fetal demise

          -  height &lt; 5'0&quot;

          -  Body Mass Index &gt; 45 kg/m2
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Joanne Street</last_name>
    <phone>902-470-7879</phone>
    <email>joanne.street@iwk.nshealth.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lorraine Chiasson, BSc, MA</last_name>
    <phone>902-470-7473</phone>
    <email>Lorraine.Chiasson@iwk.nshealth.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>IWK Health Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3K 6R8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>March 1, 2019</study_first_submitted>
  <study_first_submitted_qc>March 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2019</study_first_posted>
  <last_update_submitted>June 12, 2019</last_update_submitted>
  <last_update_submitted_qc>June 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IWK Health Centre</investigator_affiliation>
    <investigator_full_name>Allana</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <keyword>Analgesia</keyword>
  <keyword>Epidural</keyword>
  <keyword>Labor</keyword>
  <keyword>Obstetric Analgesia</keyword>
  <keyword>Obstetrical</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Labor Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 22, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/30/NCT03871530/Prot_SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

